Table 1.
Patients characteristics
| Number of patients (%) | |
|---|---|
| Age (years) | |
| Mean (standard deviation) | 61.25 (7.644) |
| Median (range) | 61.5 (49–72) |
| Gender | |
| Male | 4 (50) |
| Female | 4 (50) |
| Race | |
| Caucasian | 7 (87.5) |
| Non-Caucasian | 1 (12.5) |
| Location of primary tumor | |
| Head / Body | 5 (62.5) |
| Tail | 3 (37.5) |
| Previous treatments | |
| Radiation | 3 (37.5) |
| Surgery | 5 (75) |
| Multiple agents systemic | 8 (100) |
| Chemotherapy | |
| Number of previous lines of systemic chemotherapy | |
| 1 | 1 (12.5) |
| 2 | 3 (37.5) |
| ≥3 | 4 (50) |
| Number of metastatic sites (involved organs) | |
| 1 | 2 (25) |
| 2 | 3 (37.5) |
| ≥3 | 3 (37.5) |
| Mean (range) of pretreatment serum tumor markers | |
| CEA (ng/mL; range) | 6.367 (1–23.8) |
| CA19–9 (U/mL; range) | 1928 (6.9–8958) |